KIMBERLY LOTT: Open Payments
NPI 1306802236 · DOUGLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,612 in 68 payments from 15 companies in 2025. Trend: 2023 $1,287 · 2024 $1,294 · 2025 $1,612
Food & beverage: $1,612
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $367 |
| Novo Nordisk Inc | 14 | $336 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $201 |
| GlaxoSmithKline, LLC. | 10 | $184 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $131 |
| PFIZER INC. | 4 | $94 |
| ABBVIE INC. | 3 | $72 |
| Amgen Inc. | 4 | $67 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| Corcept Therapeutics | 1 | $20 |
Products named: FARXIGA, Wegovy, Kerendia, TRELEGY ELLIPTA, JARDIANCE, Ozempic, NURTEC ODT, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
